DALLAS, May 12, 2005 (PRIMEZONE) -- John Pentony, Publisher of StockGuru.com, announced today that the web site has initiated profile coverage for MEDirect Latino, Inc. (Pink Sheets:MLTO). Mr. Pentony spoke of the newly profiled company: "MEDirect is a company we are very proud to cover. It is clear that the company has the right vision here. As someone who has worked in Latino television, I am very familiar with MEDirect's target market. MEDirect knows its market, and understands how to reach this market in an efficient manor that should bring significant product demand as the company expands on its marketing efforts this year."
To view StockGuru's Profile of MEDirect Latino, please visit:
http://stockguru.com/profiles/mlto/index.aspx
About MEDirect Latino:
MEDirect Latino (Pink Sheets:MLTO), http://www.medirectlatino.org, is a rapidly growing, uniquely positioned provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community in the United States and Puerto Rico. MEDirect is the only company positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. The Company's current focus is the distribution of products for the treatment of Type II diabetes specifically because of its disproportionate impact and increasing diagnosis rate within the U.S. Hispanic population, noting an incidence of 120% higher than among non-Hispanic whites. Type II diabetes was also targeted because of its unique status within the Medicare reimbursement regime and because of its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These other conditions represent considerable future market potential that will allow MEDirect to efficiently scale its model by leveraging its existing client base and infrastructure.
The current Hispanic market for MEDirect's products is conservatively estimated at approximately $650MM in the continental United States. The size of the opportunity is understated by such figures as an estimated 925,000 of the over 3.1 million Hispanics in the United States over 65 eligible to receive Medicare benefits are currently collecting these benefits with an estimate that over 1.4 million of those Medicare-eligible Hispanics have diabetes (implying a potential continental U.S. market for MEDirect products of approximately $1 billion).
About StockGuru.com:
StockGuru.com and TalkingStocks.com are two key destinations on the internet for those seeking information on smallcap and microcap companies. The web sites feature companies in Profile Campaigns, Key Executive Interviews, email alerts and special reports authored by our financial writers. The web sites set the standard for communication with investors. To feature a company or to get more information, please contact our publisher, John Pentony, for more information (Telephone: 972-865-1401; Email: publisher@stockguru.com).
Forward-Looking Statements:
Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as the term is defined in the Private Litigation Reform Act of 1995. The Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Should events occur which materially affect any comments made within this press release; the Company will appropriately inform the public.
Pentony Enterprises LLC has been compensated $6000 and 12000 restricted shares for Profile Coverage.